Transpact Enterprises (BSE 542765)₹100.700.00%Medical Equipment & Supplies
In the Mar 2026 quarter (standalone), Transpact Enterprises reported sales of ₹0.08 Cr, up 14.3% from Mar 2025, and net profit of ₹0.05 Cr, down 16.7% year on year. For the year to Mar 2026, sales were ₹0.17 Cr and net profit ₹0.10 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.09 | 0.08 |
| Expenses | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.05 |
| Operating Profit | −0.02 | −0.02 | −0.02 | −0.02 | 0.05 | 0.06 | 0.04 |
| OPM % | — | — | — | — | 74.9% | 70.0% | 55.5% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 |
| Profit before tax | −0.04 | −0.04 | −0.08 | −0.06 | 0.05 | 0.06 | 0.04 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | −33.4% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.04 | −0.04 | −0.07 | −0.06 | 0.06 | 0.06 | 0.05 |
| EPS (Rs) | −0.77 | −0.77 | −1.54 | −1.28 | 1.28 | 1.28 | 1.02 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.02 | 0.14 | 0.37 | 0.00 | 0.07 | 0.17 |
| Expenses | 0.08 | 0.06 | 0.10 | 0.17 | 0.35 | 0.09 | 0.37 | 0.42 | 0.07 | 0.05 | 0.07 |
| Operating Profit | −0.06 | −0.04 | −0.08 | −0.02 | −0.33 | −0.04 | −0.20 | −0.02 | −0.05 | 0.03 | 0.11 |
| OPM % | — | — | — | −23.1% | −1,950.1% | −166.7% | −140.1% | −7.9% | — | 49.9% | 66.7% |
| Other Income | 0.00 | 0.00 | 0.00 | −0.22 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.05 |
| Profit before tax | −0.08 | −0.06 | −0.10 | −0.29 | −0.44 | −0.07 | −0.23 | −0.08 | −0.11 | 0.00 | 0.09 |
| Tax % | 0.0% | 0.0% | 0.0% | 3.6% | 2.3% | 16.6% | 0.0% | 0.0% | 0.0% | — | −12.5% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.08 | −0.06 | −0.10 | −0.31 | −0.44 | −0.07 | −0.23 | −0.08 | −0.10 | 0.02 | 0.10 |
| EPS (Rs) | −17.76 | −12.37 | −22.25 | −74.27 | −11.11 | −1.54 | −5.68 | −1.80 | −2.32 | 0.25 | 2.32 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.04 | 0.04 | 0.04 | 0.04 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
| Reserves | 0.13 | 0.10 | 0.12 | 0.03 | −0.05 | 0.50 | 0.43 | 0.21 | 0.15 | 0.06 | 0.06 | 0.15 |
| Borrowings | 0.01 | 0.03 | 0.06 | 0.35 | 0.42 | 0.25 | 0.28 | 0.28 | 0.27 | 0.04 | 0.09 | 0.05 |
| Other Liabilities | −0.02 | 0.00 | −0.01 | 0.03 | 0.09 | 0.14 | 0.26 | 0.20 | 0.21 | 0.15 | 0.14 | 0.17 |
| Total Liabilities | 0.13 | 0.17 | 0.21 | 0.45 | 0.50 | 1.28 | 1.36 | 1.08 | 1.02 | 0.64 | 0.68 | 0.76 |
| Fixed Assets | 0.12 | 0.12 | 0.17 | 0.17 | 0.34 | 0.30 | 0.26 | 0.23 | 0.19 | 0.15 | 0.12 | 0.08 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.01 | 0.05 | 0.04 | 0.28 | 0.16 | 0.98 | 1.10 | 0.85 | 0.83 | 0.49 | 0.56 | 0.68 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.20 | 0.08 | 0.19 | 0.17 | 0.00 | 0.02 | 0.02 | 0.02 | 0.00 |
| Trade receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.09 |
| Cash & equivalents | 0.02 | 0.02 | 0.02 | 0.07 | 0.02 | 0.02 | 0.06 | 0.03 | 0.02 | 0.42 | 0.02 | 0.02 |
| Total Assets | 0.13 | 0.17 | 0.21 | 0.45 | 0.50 | 1.28 | 1.36 | 1.08 | 1.02 | 0.64 | 0.68 | 0.76 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.13 | −0.06 | −0.25 | 0.08 | −1.15 | 0.02 | −0.88 | −0.02 | 0.40 | −0.41 | 0.06 |
| Cash from investing activity | 0.00 | −0.06 | 0.00 | −0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing activity | 0.11 | 0.09 | 0.28 | 0.07 | 1.13 | 0.02 | −0.28 | 0.00 | 0.00 | 0.00 | −0.03 |
| Net cash flow | 0.00 | 0.00 | 0.06 | −0.06 | 0.00 | 0.05 | −1.17 | −0.02 | 0.40 | −0.41 | 0.02 |
| Capex | 0.00 | 0.04 | 0.00 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | −0.13 | −0.11 | −0.25 | −0.13 | −1.15 | 0.02 | −0.88 | −0.02 | 0.40 | −0.41 | 0.06 |
| CFO / OP % | 171.0% | 100.0% | 267.0% | −233.0% | 335.0% | −20.0% | 414.0% | 33.0% | −650.0% | −1,000.0% | 42.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | — | — | — | — | 84 | — | 0 | 0 | 0 | — | 456 | 203 |
| Inventory days | — | — | — | — | 328 | — | — | 13 | 19 | — | — | 0 |
| Days payable | — | — | — | — | 182 | — | — | 130 | 115 | — | — | — |
| Cash conversion cycle | — | — | — | — | 231 | — | 0 | −116 | −95 | — | 457 | 204 |
| Working capital days | — | — | — | — | −282 | — | −2,678 | −926 | −385 | — | 1,550 | 912 |
| ROCE % | 0.0% | −41.2% | −24.4% | −27.3% | −11.7% | −45.6% | −5.3% | −22.1% | −8.2% | −15.2% | 0.0% | 14.0% |
For the Mar 2026 quarter, Transpact Enterprises reported sales of ₹0.08 Cr, up 14.3% year on year and net profit of ₹0.05 Cr, down 16.7% year on year. The operating margin was 55.5%.
Transpact Enterprises' sales for the year to Mar 2026 were ₹0.17 Cr.
Net profit for the year to Mar 2026 was ₹0.10 Cr. Earnings per share over the same trailing period were ₹2.32.
Transpact Enterprises reported borrowings of ₹0.05 Cr at Mar 2026, against cash and equivalents of ₹0.02 Cr.
Cash from operations was ₹0.06 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.06 Cr.